Professional Documents
Culture Documents
Atanas Koulov
Chief Scientific Officer
Clear Solutions Laboratories
atanas.koulov@clearsolutions-labs.com
Fevereiro 2, 2024, 14:00
Prevention
2. Monitoring
a. Periodic or continuous monitoring (action limits)
3. Additional characterization
Connecting People, Science and Regulation®
Particle Control Strategy
1. Control System
a. 100% VI (part of the manufacturing process)
b. Release testing (e.g. AQL)
c. Stability testing
2. Monitoring
a. Periodic or continuous monitoring (action limits)
3. Additional characterization
a. Particle investigations and assessments; facility libraries
● Compendial chapters
(USP<790>/ EP 2.9.20.)
● Compendial methods are considered validated, BUT
suitability for the product needs to be assessed
● Depending on the attributes of the product,
the inspection method can be enhanced
● A multifunctional tool:
○ Define Detectability (PoD) for different particle types/ sizes
○ Qualify inspectors
○ Basis for the design of different test sets
■ introduction/ training
■ testing/ qualification
Connecting People, Science and Regulation®
1a. 100% Visual Inspection -
Inspector qualification
● Training
○ setting up solid training programs is a critical success
factor (see PDA training courses)
● Visual acuity
● Inspector qualification - testing - challenge sets
2. Monitoring
a. Periodic or continuous monitoring (action limits)
3. Additional characterization
a. Particle investigations and assessments; facility libraries
● Additional considerations:
○ Potential intrinsic (typical product-related) particles are
mostly irrelevant
○ How do we qualify inspectors for detecting “inherent”
particles?
○ Expertise:
■ Technical
■ Understanding of pharmaceutical manufacturing
Prevention